A Debate on the Pros and Cons of 23-g vs. 25-g Vitrectomy
By: Steven Charles, M.D.; Howard Fine, M.D.; Richard F. Spaide, M.D.
Point/Counterpoint
By: David S. Boyer, M.D.; Victor H. Gonzalez, M.D.
Two physicians comment on their use of Lucentis and Macugen.
AMD Treatment Trends Call Attention to Cost/Benefit Considerations
By: Rochelle Nataloni
As AMD treatment choices grow, can comparison-shopping be far behind?
Macugen Widely Being Adopted by Retina Specialists
By: Jerry Helzner
Survey also shows high interest in Avastin and Lucentis.
Technology Update: NIDEKMP-1 MicroPerimeter
By: Rochelle Nataloni
Tracking fixation function places device in a category all its own
Employing Occupational Therapists to Assist the Low-Vision Population
By: Mary Warren, MS,OTR/L
A viable option in assisting low-vision patients
Where do Lutein and Zeaxanthin Fit?
A leading researcher discusses their roles in the AMD treatment and prevention equation.
Upfront
By: Jason S. Slakter, M.D.
Subspecialty News
By: Stephen C. Sheppard, C.P.A., C.O.E.
Face Off
By: Abdhish R. Bhavsar, M.D.
Coding Q&A
By: Riva Lee Asbell